Aptamer Group (UK) Today

APTA Stock   0.31  0.01  3.33%   

Performance

10 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Over 71

 
High
 
Low
High
Aptamer Group is selling for under 0.31 as of the 30th of November 2024; that is 3.33 percent increase since the beginning of the trading day. The stock's lowest day price was 0.3. Aptamer Group has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very ok returns during the last 90 days. Equity ratings for Aptamer Group PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Aptamer Group is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 1.92 B outstanding shares. More on Aptamer Group PLC

Moving against Aptamer Stock

  0.888E 88 EnergyPairCorr
  0.750LQQ Vodafone Group PLCPairCorr
  0.66LLOY Lloyds Banking GroupPairCorr
  0.65VOD Vodafone Group PLCPairCorr
  0.39SYME SupplyMe Capital PLCPairCorr
  0.38PREM Premier African MineralsPairCorr

Aptamer Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aptamer Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aptamer Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Executive ChairmanStephen Hull
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors)
Aptamer Group's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aptamer Group's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Aptamer Group can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aptamer Group's financial leverage. It provides some insight into what part of Aptamer Group's total assets is financed by creditors.
Liquidity
Aptamer Group cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Aptamer Group PLC has accumulated 817 K in total debt. Debt can assist Aptamer Group until it has trouble settling it off, either with new capital or with free cash flow. So, Aptamer Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Aptamer Group PLC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Aptamer to invest in growth at high rates of return. When we think about Aptamer Group's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

(190,508)
Aptamer Group PLC (APTA) is traded on London Exchange in UK and employs 34 people. Aptamer Group is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aptamer Group's market, we take the total number of its shares issued and multiply it by Aptamer Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aptamer Group PLC operates under Biotechnology sector and is part of Health Care industry. The entity has 1.92 B outstanding shares. Aptamer Group generates negative cash flow from operations
Check Aptamer Group Probability Of Bankruptcy
Ownership Allocation
Aptamer Group holds a total of 1.92 Billion outstanding shares. Aptamer Group PLC shows 13.22 percent of its outstanding shares held by insiders and 11.71 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aptamer Ownership Details

Aptamer Group PLC Risk Profiles

Although Aptamer Group's alpha and beta are two of the key measurements used to evaluate Aptamer Group's performance over the market, the standard measures of volatility play an important role as well.

Aptamer Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Aptamer Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Aptamer Group Corporate Executives

Elected by the shareholders, the Aptamer Group's board of directors comprises two types of representatives: Aptamer Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aptamer. The board's role is to monitor Aptamer Group's management team and ensure that shareholders' interests are well served. Aptamer Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aptamer Group's outside directors are responsible for providing unbiased perspectives on the board's policies.

Additional Tools for Aptamer Stock Analysis

When running Aptamer Group's price analysis, check to measure Aptamer Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aptamer Group is operating at the current time. Most of Aptamer Group's value examination focuses on studying past and present price action to predict the probability of Aptamer Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aptamer Group's price. Additionally, you may evaluate how the addition of Aptamer Group to your portfolios can decrease your overall portfolio volatility.